EnGeneIC performs research, development and manufacturing of targeted anti-cancer therapies.
Works against mutant strains including Delta
No need for refrigeration during transport and storage
No added stabilisers or chemicals
Safety and immune response clinical trial recruiting now in Melbourne
Efficacy trial planned for USA.
For more information about becoming a volunteer for the COVID-19 EDV™ Vaccine Trial contact:
Despina Anagnostou - St Vincents Hospital Melbourne
+61 3 9231 3490 Despina.Anagnostou@svha.org.au
EDV™ Technology Stimulates Both Innate and Adaptive Immune Response and Confers Long-Term Survival
Abstract Demonstrates Promising Early Results from Phase I/IIa study in Patients with Recurrent, Metastatic Pancreatic Cancer.